COMPARISON OF I-123 LABELED 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE AND 3-BETA-(4-IODOPHENYL)-N-(3-FLUOROPROPYL)NORTROPANE FOR IMAGING OF THE DOPAMINE TRANSPORTER IN THE LIVING HUMAN BRAIN
Jt. Kuikka et al., COMPARISON OF I-123 LABELED 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE AND 3-BETA-(4-IODOPHENYL)-N-(3-FLUOROPROPYL)NORTROPANE FOR IMAGING OF THE DOPAMINE TRANSPORTER IN THE LIVING HUMAN BRAIN, European journal of nuclear medicine, 22(4), 1995, pp. 356-360
Several cocaine congeners are of potential for imaging the dopamine tr
ansporter (DAT). Previous studies have shown that iodine-123 labelled
2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane ([I-123]beta-CIT) is
a promising radiotracer for imaging the serotonin (5-HT) and dopamine
(DA) transporters in the living human brain with single-photon emissio
n tomography (SPET). [I-123]beta-CIT was found to be not very practica
l for 1-day DAT imaging protocols since peak DAT uptake occurs later t
han 8 h. Here we report a pilot comparison of [I-123]beta-CIT and 2 be
ta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane ([I
-123]beta-CIT-FP), using SPET imaging in four healthy male subjects. P
eak uptake of [I-123]beta-CIT-FP into the basal ganglia occurred earli
er (3-4 h after injection of tracer) than that of [I-123]beta-CIT (>8
h). However, the specific DAT binding of [I-123]beta-CIT-FP in the bas
al ganglia was somewhat less (0.813+/-0.047) than that of [I-123]beta-
CIT (0.922+/-0.004). Imaging quality is excellent with both tracers an
d they are potentially of value for brain imaging in various neuropsyc
hiatric disorders.